RPG Life Sciences Limited (RPGLIFE.NS)
INR 2168.2
(5.05%)
INR 2168.2
(5.05%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.63 Billion INR | -46.14% |
| 2022 | 2.54 Billion INR | 18.36% |
| 2021 | 2.15 Billion INR | 12.67% |
| 2020 | 1.91 Billion INR | -3.11% |
| 2019 | 1.97 Billion INR | 1.27% |
| 2018 | 1.94 Billion INR | -0.85% |
| 2017 | 1.96 Billion INR | 7.41% |
| 2016 | 1.82 Billion INR | 5.69% |
| 2015 | 1.72 Billion INR | 11.82% |
| 2014 | 1.54 Billion INR | -1.68% |
| 2013 | 1.57 Billion INR | 14.6% |
| 2012 | 1.37 Billion INR | 6.43% |
| 2011 | 1.29 Billion INR | 15.99% |
| 2010 | 1.11 Billion INR | 22.71% |
| 2009 | 906.32 Million INR | 11.49% |
| 2008 | 812.9 Million INR | 14.95% |
| 2007 | 707.15 Million INR | 24.4% |
| 2006 | 568.44 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 386 Million INR | 17.86% |
| 2023 Q2 | 757.8 Million INR | 132.67% |
| 2023 Q1 | 325.7 Million INR | -51.37% |
| 2023 FY | 1.37 Billion INR | -46.14% |
| 2023 Q4 | 327.5 Million INR | -54.37% |
| 2023 Q3 | 717.7 Million INR | -5.29% |
| 2022 Q2 | 635.6 Million INR | 3.55% |
| 2022 Q4 | 669.8 Million INR | 6.61% |
| 2022 FY | 2.54 Billion INR | 18.36% |
| 2022 Q1 | 613.8 Million INR | 35.05% |
| 2022 Q3 | 628.3 Million INR | -1.15% |
| 2021 Q4 | 454.5 Million INR | -23.2% |
| 2021 Q2 | 564.1 Million INR | 4.1% |
| 2021 Q3 | 591.8 Million INR | 4.91% |
| 2021 FY | 2.15 Billion INR | 12.67% |
| 2021 Q1 | 541.9 Million INR | 43.21% |
| 2020 Q2 | 512.4 Million INR | 3.12% |
| 2020 FY | 1.91 Billion INR | -3.11% |
| 2020 Q3 | 522.6 Million INR | 1.99% |
| 2020 Q4 | 378.4 Million INR | -27.59% |
| 2020 Q1 | 496.9 Million INR | 17.55% |
| 2019 Q2 | 536.3 Million INR | 7.52% |
| 2019 FY | 1.97 Billion INR | 1.27% |
| 2019 Q4 | 422.7 Million INR | -18.24% |
| 2019 Q3 | 517 Million INR | -3.6% |
| 2019 Q1 | 498.8 Million INR | 39.49% |
| 2018 Q2 | 536.4 Million INR | 3.35% |
| 2018 Q1 | 519 Million INR | 1.63% |
| 2018 Q3 | 534.8 Million INR | -0.3% |
| 2018 Q4 | 357.6 Million INR | -33.13% |
| 2018 FY | 1.94 Billion INR | -0.85% |
| 2017 FY | 1.96 Billion INR | 7.41% |
| 2017 Q3 | 539 Million INR | 7.67% |
| 2017 Q4 | 510.7 Million INR | -5.25% |
| 2017 Q1 | 511.3 Million INR | 14.67% |
| 2017 Q2 | 500.6 Million INR | -2.09% |
| 2016 Q4 | 445.9 Million INR | 7.55% |
| 2016 Q3 | 414.6 Million INR | -5.21% |
| 2016 Q2 | 437.4 Million INR | -1.58% |
| 2016 FY | 1.82 Billion INR | 5.69% |
| 2016 Q1 | 444.4 Million INR | 1.0% |
| 2015 Q4 | 440 Million INR | -2.59% |
| 2015 Q2 | 426.6 Million INR | 5.13% |
| 2015 Q3 | 451.7 Million INR | 5.88% |
| 2015 Q1 | 405.8 Million INR | -1.62% |
| 2015 FY | 1.72 Billion INR | 11.82% |
| 2014 Q1 | 352.9 Million INR | -3.79% |
| 2014 Q4 | 412.5 Million INR | 16.92% |
| 2014 Q3 | 352.8 Million INR | -17.7% |
| 2014 Q2 | 428.7 Million INR | 21.48% |
| 2014 FY | 1.54 Billion INR | -1.68% |
| 2013 Q3 | 425.4 Million INR | 7.18% |
| 2013 Q1 | 373.7 Million INR | 5.8% |
| 2013 Q2 | 396.9 Million INR | 6.21% |
| 2013 Q4 | 366.8 Million INR | -13.78% |
| 2013 FY | 1.57 Billion INR | 14.6% |
| 2012 Q1 | 316.5 Million INR | 0.0% |
| 2012 FY | 1.37 Billion INR | 6.43% |
| 2012 Q3 | 343.8 Million INR | -4.37% |
| 2012 Q2 | 359.5 Million INR | 13.59% |
| 2012 Q4 | 353.2 Million INR | 2.73% |
| 2011 FY | 1.29 Billion INR | 15.99% |
| 2010 FY | 1.11 Billion INR | 22.71% |
| 2009 FY | 906.32 Million INR | 11.49% |
| 2008 FY | 812.9 Million INR | 14.95% |
| 2007 FY | 707.15 Million INR | 24.4% |
| 2006 FY | 568.44 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Hester Biosciences Limited | 908.84 Million INR | -79.955% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -16.589% |
| Ipca Laboratories Limited | 18.98 Billion INR | 91.386% |
| Aarti Drugs Limited | 1.16 Billion INR | -40.088% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | 46.803% |
| Albert David Limited | 1.02 Billion INR | -59.383% |
| Alembic Limited | 872.45 Million INR | -87.459% |
| Alkem Laboratories Limited | 32.83 Billion INR | 95.019% |
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 89.694% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -258.989% |
| Bajaj HealthCare Limited | 985.34 Million INR | -65.982% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -23880.938% |
| Brooks Laboratories Limited | 51.18 Million INR | -3095.584% |
| Eris Lifesciences Limited | 4.94 Billion INR | 66.912% |
| FDC Limited | 3.49 Billion INR | 53.268% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | 85.95% |
| Gufic Biosciences Limited | 1.18 Billion INR | -37.832% |
| Hikal Limited | 4.46 Billion INR | 63.361% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | 23.006% |
| Ind-Swift Limited | 946.56 Million INR | -72.782% |
| Innova Captab Limited | 931.03 Million INR | -75.666% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | 25.693% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -272.934% |
| Jubilant Pharmova Limited | 14.45 Billion INR | 88.685% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -296.555% |
| Laurus Labs Limited | 11.9 Billion INR | 86.268% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -52.255% |
| Lupin Limited | 125.09 Billion INR | 98.693% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -908.149% |
| Medico Remedies Limited | 59.67 Million INR | -2640.679% |
| Morepen Laboratories Limited | 1.98 Billion INR | 17.709% |
| Nectar Lifesciences Limited | 932.7 Million INR | -75.351% |
| Orchid Pharma Limited | 800.77 Million INR | -104.241% |
| Procter & Gamble Health Limited | 2.99 Billion INR | 45.4% |
| Sigachi Industries Limited | 579.88 Million INR | -182.038% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | 35.966% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 98.939% |
| Themis Medicare Limited | 1.12 Billion INR | -45.275% |
| Unichem Laboratories Limited | 6.72 Billion INR | 75.683% |
| Vaishali Pharma Limited | 84.02 Million INR | -1846.352% |
| Venus Remedies Limited | 1.91 Billion INR | 14.653% |
| Wanbury Limited | 978.96 Million INR | -67.064% |
| Windlas Biotech Limited | 1 Billion INR | -62.492% |
| ZIM Laboratories Limited | 1.01 Billion INR | -61.442% |
| Sakar Healthcare Limited | 204.07 Million INR | -701.405% |
| Aurobindo Pharma Limited | 55.65 Billion INR | 97.062% |
| Divi's Laboratories Limited | 14.17 Billion INR | 88.458% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | 33.879% |
| Mankind Pharma Limited | 29.27 Billion INR | 94.413% |
| Sequent Scientific Limited | 2.9 Billion INR | 43.639% |
| Neuland Laboratories Limited | 2.92 Billion INR | 44.176% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 88.944% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 96.517% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 98.694% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | 21.897% |
| Wockhardt Limited | 8.48 Billion INR | 80.713% |
| Bal Pharma Limited | 555.62 Million INR | -194.353% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 98.294% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -15.239% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -2705.894% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | 24.787% |
| Shilpa Medicare Limited | 3.33 Billion INR | 50.947% |
| Valiant Laboratories Limited | 138.02 Million INR | -1084.896% |
| Ajanta Pharma Limited | 30.46 Billion INR | 94.631% |
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -11407.071% |
| Granules India Limited | 10.31 Billion INR | 84.141% |
| Medicamen Biotech Limited | 335.16 Million INR | -387.966% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -373.19% |
| Piramal Enterprises Limited | 63.65 Billion INR | 97.431% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 92.365% |
| NATCO Pharma Limited | 10.05 Billion INR | 83.739% |
| Suven Life Sciences Limited | 109.75 Million INR | -1390.205% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -3443.418% |
| Strides Pharma Science Limited | 9.16 Billion INR | 82.15% |
| Indoco Remedies Limited | 12.06 Billion INR | 86.44% |
| Alpa Laboratories Limited | 127.38 Million INR | -1183.954% |
| Lasa Supergenerics Limited | 291.17 Million INR | -461.692% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 46.844% |